Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffini Voss

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentTiffini Voss, Paulette Triglia, Yan G Ni, et al.
The New England Journal of Medicine|August 16, 2013
A pilot study of focused ultrasound thalamotomy for essential tremorW Jeffrey Elias, Diane Huss, Tiffini Voss, et al.
Journal of Clinical Pharmacology|November 15, 2017
Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot SamplingChi-Chung Li, Marissa Dockendorf, Ken Kowalski, et al.
The New England Journal of Medicine|May 3, 2018
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's DiseaseMichael F Egan, James Kost, Pierre N Tariot, et al.
Brain : a Journal of Neurology|November 30, 2020
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brainCyrille Sur, James Kost, David Scott, et al.
The New England Journal of Medicine|April 11, 2019
Randomized Trial of Verubecestat for Prodromal Alzheimer's DiseaseMichael F Egan, James Kost, Tiffini Voss, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 13, 2020
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's diseaseAlette M Wessels, Christopher Lines, Robert A Stern, et al.
Journal of Parkinson'S Disease|April 25, 2022
An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson's DiseaseSusan J Lee, Peter M Shaw, Bob Thornton, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Alzheimer'S Research & Therapy|August 8, 2019
Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer's diseaseMichael F Egan, Yuki Mukai, Tiffini Voss, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentTiffini Voss, Paulette Triglia, Yan G Ni, et al.
The New England Journal of Medicine|August 16, 2013
A pilot study of focused ultrasound thalamotomy for essential tremorW Jeffrey Elias, Diane Huss, Tiffini Voss, et al.
Journal of Clinical Pharmacology|November 15, 2017
Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot SamplingChi-Chung Li, Marissa Dockendorf, Ken Kowalski, et al.
The New England Journal of Medicine|May 3, 2018
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's DiseaseMichael F Egan, James Kost, Pierre N Tariot, et al.
Brain : a Journal of Neurology|November 30, 2020
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brainCyrille Sur, James Kost, David Scott, et al.
The New England Journal of Medicine|April 11, 2019
Randomized Trial of Verubecestat for Prodromal Alzheimer's DiseaseMichael F Egan, James Kost, Tiffini Voss, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 13, 2020
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's diseaseAlette M Wessels, Christopher Lines, Robert A Stern, et al.
Journal of Parkinson'S Disease|April 25, 2022
An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson's DiseaseSusan J Lee, Peter M Shaw, Bob Thornton, et al.
Pageof 2